HHS Description Of Drug Coverage In Exchange Plans Likely To Be Broad, Flexible - Report
This article was originally published in The Pink Sheet Daily
Executive Summary
A report commissioned by Pfizer focuses on how HHS might carry out its responsibilities of defining the minimum requirements for drug coverage in the Affordable Care Act exchange plans.
You may also be interested in...
HHS Essential Health Benefits Standards Must Reflect Cost Concerns – IoM
HHS must make controlling costs a key consideration as it develops and maintains the "essential health benefits" package that private insurers must adopt in plans offered to individuals and small businesses beginning in 2014, an Institute of Medicine expert committee recommends in a report released Oct. 7.
HHS Essential Health Benefits Standards Must Reflect Cost Concerns – IoM
HHS must make controlling costs a key consideration as it develops and maintains the "essential health benefits" package that private insurers must adopt in plans offered to individuals and small businesses beginning in 2014, an Institute of Medicine expert committee recommends in a report released Oct. 7.
HHS Essential Health Benefits Standards Must Reflect Cost Concerns - IoM
Institute of Medicine releases recommendations on the development of EHB, under which comparative effectiveness research would play a key role in future updates to the EHB package.